(Q34150923)

31 July 2017

Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children (English)

1 reference

31 July 2017

1 reference

1 reference

10

Irja Lutsar

1 reference

31 July 2017

Hasan Jafri

7

0 references

Thomas J Walsh

1

object named as

Thomas J Walsh

1 reference

31 July 2017

9

Nigel J Klein

1 reference

31 July 2017

Timothy Driscoll

2

1 reference

31 July 2017

Peter A Milligan

3

1 reference

31 July 2017

Nolan D Wood

4

1 reference

31 July 2017

Haran Schlamm

5

1 reference

31 July 2017

Andreas H Groll

6

1 reference

31 July 2017

Antonio C Arrieta

8

1 reference

31 July 2017

language of work or name

English

0 references

publication date

26 July 2010

1 reference

Antimicrobial Agents and Chemotherapy

31 July 2017

1 reference

31 July 2017

54

1 reference

31 July 2017

10

1 reference

31 July 2017

4116-4123

1 reference

Voriconazole pharmacokinetics and pharmacodynamics in children

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Mycoses in pediatric patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Voriconazole therapy in children with cystic fibrosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Risk factors for mortality in children with candidemia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Newer systemic antifungal agents : pharmacokinetics, safety and efficacy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Voriconazole -- better chances for patients with invasive mycoses.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Biochemistry and molecular biology of the human CYP2C subfamily

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Antifungal therapeutic drug monitoring: established and emerging indications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Hallucinations during voriconazole therapy

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Identification of the Cytochrome P450 Enzymes Involved in theN-Oxidation of Voriconazole

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Determination of a new antifungal agent, voriconazole, by multidimensional high-performance liquid chromatography with direct plasma injection onto a size-exclusion column

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944563

Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20660687

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00896-10

1 reference

31 July 2017

1 reference

31 July 2017

1 reference